Stupp R, Hegi ME, Mason WP et al (2009) Effects of radiotherapy with concomitant and adjuvant temozolomide versus radiotherapy alone on survival in glioblastoma in a randomised phase III study: 5-year analysis of the EORTC-NCIC trial. Lancet Oncol 10:459–466

CAS  PubMed  Article  Google Scholar 

Stupp R, Mason WP, van den Bent MJ et al (2005) Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma. N Engl J Med 352:987–996

CAS  PubMed  Article  Google Scholar 

Singh SK, Clarke ID, Hide T et al (2004) Cancer stem cells in nervous system tumors. Oncogene 23:7267–7273

CAS  PubMed  Article  Google Scholar 

Singh SK, Hawkins C, Clarke ID et al (2004) Identification of human brain tumour initiating cells. Nature 432:396–401

CAS  PubMed  Article  Google Scholar 

Andersen BM, Faust Akl C, Wheeler MA et al (2021) Glial and myeloid heterogeneity in the brain tumour microenvironment. Nat Rev Cancer 21:786–802

CAS  PubMed  Article  Google Scholar 

Hernandez A, Domenech M, Munoz-Marmol AM et al (2021) Glioblastoma: relationship between metabolism and immunosuppressive microenvironment. Cells 10(12):3529

CAS  PubMed  PubMed Central  Article  Google Scholar 

Neftel C, Laffy J, Filbin MG et al (2019) An integrative model of cellular states, plasticity, and genetics for glioblastoma. Cell 178(835–849):e821

Google Scholar 

Yang K, Wu Z, Zhang H et al (2022) Glioma targeted therapy: insight into future of molecular approaches. Mol Cancer 21:39

CAS  PubMed  PubMed Central  Article  Google Scholar 

Hide T, Komohara Y, Miyasato Y et al (2018) Oligodendrocyte progenitor cells and macrophages/microglia produce glioma stem cell niches at the tumor border. EBioMedicine 30:94–104

PubMed  PubMed Central  Article  Google Scholar 

Hide T, Shibahara I, Kumabe T (2019) Novel concept of the border niche: glioblastoma cells use oligodendrocytes progenitor cells (GAOs) and microglia to acquire stem cell-like features. Brain Tumor Pathol 36:63–73

PubMed  Article  Google Scholar 

Ito N, Katoh K, Kushige H et al (2018) Ribosome incorporation into somatic cells promotes lineage transdifferentiation towards multipotency. Sci Rep 8:1634

PubMed  PubMed Central  Article  CAS  Google Scholar 

Shirakawa Y, Hide T, Yamaoka M et al (2020) Ribosomal protein S6 promotes stem-like characters in glioma cells. Cancer Sci 111:2041–2051

CAS  PubMed  PubMed Central  Article  Google Scholar 

Domenech M, Hernandez A, Plaja A et al (2021) Hypoxia: the cornerstone of glioblastoma. Int J Mol Sci 22(22):12608

CAS  PubMed  PubMed Central  Article  Google Scholar 

Vartanian A, Singh SK, Agnihotri S et al (2014) GBM’s multifaceted landscape: highlighting regional and microenvironmental heterogeneity. Neuro Oncol 16:1167–1175

PubMed  PubMed Central  Article  Google Scholar 

Basheer AS, Abas F, Othman I et al (2021) Role of inflammatory mediators, macrophages, and neutrophils in glioma maintenance and progression: mechanistic understanding and potential therapeutic applications. Cancers (Basel) 13(16):4226

CAS  Article  Google Scholar 

Simon T, Jackson E, Giamas G (2020) Breaking through the glioblastoma micro-environment via extracellular vesicles. Oncogene 39:4477–4490

CAS  PubMed  PubMed Central  Article  Google Scholar 

Mohiuddin E, Wakimoto H (2021) Extracellular matrix in glioblastoma: opportunities for emerging therapeutic approaches. Am J Cancer Res 11:3742–3754

CAS  PubMed  PubMed Central  Google Scholar 

Broekman ML, Maas SLN, Abels ER et al (2018) Multidimensional communication in the microenvirons of glioblastoma. Nat Rev Neurol 14:482–495

PubMed  PubMed Central  Article  Google Scholar 

Kressler D, Hurt E, Bassler J (2010) Driving ribosome assembly. Biochim Biophys Acta 1803:673–683

CAS  PubMed  Article  Google Scholar 

Zhou X, Liao WJ, Liao JM et al (2015) Ribosomal proteins: functions beyond the ribosome. J Mol Cell Biol 7:92–104

CAS  PubMed  PubMed Central  Article  Google Scholar 

Zhang D, Chen HP, Duan HF et al (2016) Aggregation of ribosomal protein S6 at nucleolus is cell cycle-controlled and its function in Pre-rRNA processing is phosphorylation dependent. J Cell Biochem 117:1649–1657

CAS  PubMed  Article  Google Scholar 

Biever A, Valjent E, Puighermanal E (2015) Ribosomal protein S6 phosphorylation in the nervous system: from regulation to function. Front Mol Neurosci 8:75

PubMed  PubMed Central  Article  CAS  Google Scholar 

Chow S, Minden MD, Hedley DW (2006) Constitutive phosphorylation of the S6 ribosomal protein via mTOR and ERK signaling in the peripheral blasts of acute leukemia patients. Exp Hematol 34:1183–1191

CAS  PubMed  Article  Google Scholar 

Chen B, Tan Z, Gao J et al (2015) Hyperphosphorylation of ribosomal protein S6 predicts unfavorable clinical survival in non-small cell lung cancer. J Exp Clin Cancer Res 34:126

PubMed  PubMed Central  Article  CAS  Google Scholar 

Khalaileh A, Dreazen A, Khatib A et al (2013) Phosphorylation of ribosomal protein S6 attenuates DNA damage and tumor suppression during development of pancreatic cancer. Cancer Res 73:1811–1820

CAS  PubMed  Article  Google Scholar 

Puchalski RB, Shah N, Miller J et al (2018) An anatomic transcriptional atlas of human glioblastoma. Science 360:660–663

CAS  PubMed  PubMed Central  Article  Google Scholar 

Shirakawa Y, Ohta K, Miyake S et al (2021) Glioma cells acquire stem-like characters by extrinsic ribosome stimuli. Cells 10(11):2970

CAS  PubMed  PubMed Central  Article  Google Scholar 

Court FA, Hendriks WT, MacGillavry HD et al (2008) Schwann cell to axon transfer of ribosomes: toward a novel understanding of the role of glia in the nervous system. J Neurosci 28:11024–11029

CAS  PubMed  PubMed Central  Article  Google Scholar 

Lopez-Leal R, Alvarez J, Court FA (2016) Origin of axonal proteins: Is the axon-schwann cell unit a functional syncytium? Cytoskeleton (Hoboken) 73:629–639

CAS  Article  Google Scholar 

Pinto G, Saenz-de-Santa-Maria I, Chastagner P et al (2021) Patient-derived glioblastoma stem cells transfer mitochondria through tunneling nanotubes in tumor organoids. Biochem J 478:21–39

CAS  PubMed  Article  Google Scholar 

Yi YW, You KS, Park JS et al (2021) Ribosomal protein S6: a potential therapeutic target against cancer? Int J Mol Sci 23(1):48

PubMed  PubMed Central  Article  CAS  Google Scholar 

Pecoraro A, Pagano M, Russo G et al (2021) Ribosome biogenesis and cancer: overview on ribosomal proteins. Int J Mol Sci 22(11):5496

CAS  PubMed  PubMed Central  Article  Google Scholar 

Orgebin E, Lamoureux F, Isidor B et al (2020) Ribosomopathies: new therapeutic perspectives. Cells 9(9):2080

CAS  PubMed Central  Article  Google Scholar 

Norris K, Hopes T, Aspden JL (2021) Ribosome heterogeneity and specialization in development. Wiley Interdiscip Rev RNA 12:e1644

CAS  PubMed  PubMed Central  Article  Google Scholar 

Warner JR, McIntosh KB (2009) How common are extraribosomal functions of ribosomal proteins? Mol Cell 34:3–11

CAS  PubMed  PubMed Central  Article  Google Scholar 

Narla A, Ebert BL (2010) Ribosomopathies: human disorders of ribosome dysfunction. Blood 115:3196–3205

CAS  PubMed  PubMed Central  Article  Google Scholar 

Barna M, Pusic A, Zollo O et al (2008) Suppression of Myc oncogenic activity by ribosomal protein haploinsufficiency. Nature 456:971–975

CAS  PubMed  PubMed Central  Article  Google Scholar 

Bursac S, Prodan Y, Pullen N et al (2021) Dysregulated ribosome biogenesis reveals therapeutic liabilities in cancer. Trends Cancer 7:57–76

CAS  PubMed  Article  Google Scholar 

El Khoury W, Nasr Z (2021) Deregulation of ribosomal proteins in human cancers. Biosci Rep. https://doi.org/10.1042/BSR20211577

Article  PubMed  PubMed Central  Google Scholar 

Jeon YJ, Kim IK, Hong SH et al (2008) Ribosomal protein S6 is a selective mediator of TRAIL-apoptotic signaling. Oncogene 27:4344–4352

CAS  PubMed  Article  Google Scholar 

Yanai A, Inoue N, Yagi T et al (2015) Activation of mTOR/S6K but not MAPK pathways might be associated with high Ki-67, ER(+), and HER2(-) breast cancer. Clin Breast Cancer 15:197–203